Motilal Oswal recommended Neutral rating on IPCA Laboratories with a target price of Rs 860 in its research report dated October 22, 2023.

Neutral IPCA Laboratories; target of Rs 860: Motilal Oswal

Shares of Ipca Laboratories hit a 52-week high of Rs 1,003.75, surging 7 per cent on the BSE in Monday’s intra-day trade after the pharmaceutical company said it received voluntary action indicated (VAI) classification from the United States Food and Drug Administration (USFDA) for its Ratlam, Madhya Pradesh manufacturing facility. The stock of Ipca Lab surpassed its previous high of Rs 981.20 touched on October 18, 2023. It was quoting at its highest level since August 2022. The average trading volumes at the counter jumped over three-fold today. Ekta Batra with the details. 

#ipcalaboratories #ipcalaboratoriesstock #usfda #ratlamfacility #cnbctv18 #businessnews #businessnewstoday #businessnewsinenglish #sharemarkettoday   


🔴CNBC TV18 LIVE TV: https://youtube.com/live/P857H4ej-MQ
SUBSCRIBE to our Channel: https://bit.ly/3nvEcxf
---------------------------------------------------------------------------------------------------------------------
                               👑 Check Out Top CNBC TV18 Playlist Videos: 

🔹CNBC TV18 Classic Interviews: https://www.youtube.com/playlist?list=PLjq9mRS1PfGDmfXVg7XEQngsCY9RoS-fv

🔹CNBC TV18 Digital: https://www.youtube.com/playlist?list=PLjq9mRS1PfGDCcaVZ_82M9vhLo9lGJYzo

🔹CNBC TV18 Weekend Special: https://www.youtube.com/playlist?list=PLjq9mRS1PfGBHEa5NnoKuUsX5GwxEGuri

🔹CNBC TV18 Next-Gen: https://www.youtube.com/playlist?list=PLjq9mRS1PfGA6roe9q3J9fq_gBIDjX2w7

🔹Overdrive Show: https://www.youtube.com/playlist?list=PLjq9mRS1PfGCnSVjfbWfNCJLrv-CqfGmH
🔹CNBC TV18 Newsreels: https://www.youtube.com/playlist?list=PLjq9mRS1PfGCmABWWQRX4NqGLCtScwqex

🔹Young Turks: https://www.youtube.com/playlist?list=PLjq9mRS1PfGBZaN1e38X2ZmevnU1e1NJs

🔹Startup Streets: https://www.youtube.com/playlist?list=PLjq9mRS1PfGD3CzrtMr_VJRbIly6sfyFI

------------------------------------------------------------------------------------
You can also connect with CNBC-TV18 News Online
Catch the latest news: https://bit.ly/2YbpXBM

Follow CNBC-TV18 round the clock: https://www.cnbctv18.com/live-tv/

Stay updated with all the market action in real time: https://www.cnbctv18.com/market-live/

You can also stay updated with all the latest news on-the-go with CNBC-TV18 Minis: https://www.cnbctv18.com/minis/

Like us on Facebook: https://www.facebook.com/cnbctv18india/
Follow us on Twitter: https://twitter.com/CNBCTV18News
Follow us on Instagram: https://www.instagram.com/cnbctv18india/
Catch us on: Linkedin: https://in.linkedin.com/company/cnbc-tv18
n18oc_business

About CNBC-TV18: India's leading business news channel, CNBC-TV18 offers the most comprehensive coverage of businesses, the economy and the financial markets. Catch all your favourite shows, exclusive videos, big-ticket interviews and more here.

Ipca Labs Hits 52-Week High On Favourable US FDA Report For Its Ratlam Facility | CNBC TV18

#stockmarket #stockrecommendation #ipcalab 
On broader charts, IPCA Laboratories stock has given afresh breakout above the falling trend line of downward sloping channel, which suggests for limited downside in prices. Traders can buy for a target of Rs 1080 and a stop loss of Rs 830,” Shitij Gandhi, Senior Technical Analyst, SMC Global Securities, said.

► Subscribe to The Economic Times for the latest video updates. It's free! - https://www.youtube.com/TheEconomicTimes?sub_confirmation=1

► More Videos @ ETTV - https://economictimes.indiatimes.com/TV

► https://EconomicTimes.com

► For business news on the go, download ET app:
https://etapp.onelink.me/tOvY/EconomicTimesApp

Follow ET on:

► Facebook - https://www.facebook.com/EconomicTimes 
► Twitter - https://www.twitter.com/economictimes
► LinkedIn - https://www.linkedin.com/company/economictimes
► Instagram - https://www.instagram.com/the_economic_times
► Flipboard - https://flipboard.com/@economictimes

#news #latestnews #economictimes #ET #TheEconomicTimes #businessnews

Stock Radar I  IPCA Laboratories likely to top 1000 levels in the next 5-7 weeks: Shitij Gandhi

The short build-up was seen in 79 stocks. These included Ipca Laboratories, Delta Corp, SBI Card, NALCO, and Vodafone Idea. An increase in OI along with a fall in price points to a build-up of short positions.

Trade setup for Wednesday: Top 15 things to know before the opening bell

What does the August export data indicate for pharma companies?

The recent reports on the pharmaceutical export data appear to be a mixed bag, according to #JMFinancial. 

Here's Monal Sanghvi with the details. 

Read: https://bit.ly/3ZtvXUU

--------------------------------------------------------------------------------------------------------------------
For more videos subscribe to our channel: http://bit.ly/32JXa74
Visit BQ Prime for more news: https://www.bqprime.com/
Don't enter the stock market unaware. Read all Research Reports here: https://www.bqprime.com/research-reports

For the latest business news and analysis
Subscribe to our Newsletters here: https://www.bqprime.com/my-bq/newsletter
Subscribe to our Telegram channel: https://t.me/BQPrime

Follow BQ Prime here
Twitter: https://twitter.com/bqprime
Facebook: https://www.facebook.com/BQPrime/
LinkedIn: https://www.linkedin.com/company/13184554/
Instagram: https://www.instagram.com/bqprime/
Pinterest: https://in.pinterest.com/BQPrimeNews/

Laurus Labs, Syngene, Ipca, Gland Pharma Report Export Growth In August | BQ Prime

The VAI classification, considered the second best, comes after the pharma company’s Piparia facility in Silvassa had undergone US FDA inspection in April.

Ipca Laboratories gains 3% on USFDA classification

Motilal Oswal recommended Neutral rating on Ipca Laboratories with a target price of Rs 840 in its research report dated August 12, 2023.

Neutral Ipca Laboratories; target of Rs 840: Motilal Oswal

Based on the OI percentage, 81 stocks were on the short-covering list. These included ITC, Granules India, Ipca Laboratories, Lupin, and Atul. A decrease in OI along with a price increase is an indication of short-covering.

Trade setup for Tuesday: Top 15 things to know before the opening bell

Prabhudas Lilladher recommended hold rating on Ipca Laboratories with a target price of Rs 880 in its research report dated August 13, 2023.

Hold Ipca Laboratories; target of Rs 880: Prabhudas Lilladher

Ipca Laboratories picked 33.38% stake in Unichem Labs after CCI approval.

Unichem Labs erases early gains from Ipca deal as profit-booking kicks in

Though huge buying was seen in Campus Activewear, the stock fell 4.3 percent to Rs 290 amid weak equity market conditions

Bulk Deals | Ipca Labs picks 33.38% stake in Unichem; Madhusudan Kela’s wife buys 5.3% stake in Niyogin

Price return has been average, nothing exciting

Performance

Seems to be overvalued vs the market average

Valuation

Lagging behind the market in financials growth

Growth

Showing good signs of profitability & efficiency

Profitability

The stock is overpriced but is not in the overbought zone

Current price is more than the intrinsic value

Fundamentals

Good time to consider, stock is not in the overbought zone

Technicals

Entry point

Promoter pledged holding

Unsolicited messages

Default probability

Red flags

Ipca Laboratories Limited is engaged in pharmaceuticals business. The Company is a manufacturer and supplier of over 10 active pharmaceutical ingredients (APIs).